Organon and ObsEva to collaborate on preterm labour treatment
Organon will license the global development, manufacturing and commercial rights to investigational treatment ebopiprant
Read More
Tag: Organon
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
